Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)

68.26 +4.86 (+7.67%) At close: 03:00PM CST

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

No. 31 Science Park Road
Changping District
Beijing 102206
China
86 10 5952 8888
https://www.ystwt.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 3,843

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zixin Qiu	Chairman & GM	N/A	N/A	1963
Mr. Yiyong Zhao	Chief Financial Officer	N/A	N/A	1971
Mr. Yimin Li	Chief Engineer	N/A	N/A	1957
Mr. Xiangzhong Ye	Deputy GM & Director	N/A	N/A	1967
Ms. Lingzhi Zhao	Deputy GM & Director	N/A	N/A	1963
Ms. Bo Xie	Board Secretary	N/A	N/A	1984
Mr. Tao Yu	Board Secretary	N/A	N/A	1975

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.

Corporate governance

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.